Hepatitis C – Peer insights on barriers and motivators to Direct-Acting Antiviral (DAA) treatment uptake

H

ARCSHS, 2018

The knowledge and experience of people who inject drugs (PWID) within peer programs is a vital asset to strategies for the scale-up of DAA treatment among PWID (Brown and Reeders, 2016). This study is focused on translating these “real time” peer insights into resources that support policy and programs to tailor to the needs of communities of people who inject.

This tailoring is critical to achieving the goal of eliminating hepatitis C. This broadsheet is the first of a series that will be produced over the duration of the project. This series will present current peer insights from the peer workers and other members of the people who inject community on the access to and uptake of the new hepatitis C treatment.

This broadsheet provides background to the study and presents an overview of the attitudes, beliefs and experiences of PWID related to the access and scale-up of direct acting antiviral treatment among this community.

A research project by the Australian Research Centre in Sex, Health and Society in collaboration with peer-based organisations – Peer Based Harm Reduction WA, NSW Users and AIDS Association and Harm Reduction Victoria.

By J Pope

Your sidebar area is currently empty. Hurry up and add some widgets.